Dew. Believe AMRN is halted FDA appeared to inadvertently leak their position re new label , in response to a citizen petition asking them to require Amarin to run tests on the placebo used . The FDA denied the petition and laid out the reasons why ....mineral oil placebo had little affect on trial results and benefit was seen across multiple sub groups Kiwi
Market Data 
Markets 
AI
